Man Group’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | -$270K | – | 2132 |
|
|
2023
Q1 | – | Sell |
-5,206
| Closed | -$176K | – | 1701 |
|
|
2022
Q4 | $176K | Buy |
5,206
+667
| +15% | +$22.6K | ﹤0.01% | 1794 |
|
|
2022
Q3 | $223K | Buy |
+4,539
| New | +$223K | ﹤0.01% | 1709 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1897 |
|
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$587K | – | 2161 |
|
|
2021
Q4 | $587K | Buy |
6,000
+20
| +0.3% | +$1.96K | ﹤0.01% | 1473 |
|
|
2021
Q3 | $746K | Buy |
5,980
+799
| +15% | +$99.7K | ﹤0.01% | 1429 |
|
|
2021
Q2 | $650K | Sell |
5,181
-1,891
| -27% | -$237K | ﹤0.01% | 1489 |
|
|
2021
Q1 | $960K | Sell |
7,072
-2,444
| -26% | -$332K | ﹤0.01% | 1301 |
|
|
2020
Q4 | $865K | Buy |
9,516
+1,669
| +21% | +$152K | ﹤0.01% | 1448 |
|
|
2020
Q3 | $584K | Buy |
7,847
+3,069
| +64% | +$228K | ﹤0.01% | 1514 |
|
|
2020
Q2 | $407K | Buy |
4,778
+3,491
| +271% | +$297K | ﹤0.01% | 1497 |
|
|
2020
Q1 | $93K | Sell |
1,287
-27,418
| -96% | -$1.98M | ﹤0.01% | 1508 |
|
|
2019
Q4 | $2.05M | Sell |
28,705
-92,418
| -76% | -$6.6M | 0.01% | 1322 |
|
|
2019
Q3 | $6.36M | Sell |
121,123
-763
| -0.6% | -$40.1K | 0.02% | 755 |
|
|
2019
Q2 | $6.55M | Buy |
121,886
+217
| +0.2% | +$11.7K | 0.02% | 836 |
|
|
2019
Q1 | $8.65M | Buy |
121,669
+103,854
| +583% | +$7.38M | 0.03% | 650 |
|
|
2018
Q4 | $1.42M | Buy |
17,815
+9,238
| +108% | +$737K | 0.01% | 1331 |
|
|
2018
Q3 | $4M | Buy |
8,577
+4,989
| +139% | +$2.33M | 0.01% | 1102 |
|
|
2018
Q2 | $1.43M | Buy |
+3,588
| New | +$1.43M | 0.01% | 1479 |
|